Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Rabeprazole and Esomeprazole Reflux Assessment Trial (TREAT)

NCT00464308 is registered in ClinicalTrials.gov with Janssen-Cilag Pty Ltd as lead sponsor.

NCT NCT00464308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00464308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Rabeprazole and Esomeprazole Reflux Assessment Trial (TREAT)
Lead sponsor
Janssen-Cilag Pty Ltd
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2006
Completion date
May 31, 2008
Enrollment
1,392 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

gastro-oesophageal reflux